Document Detail


Interventional therapy for acute myocardial infarction.
MedLine Citation:
PMID:  11480379     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Percutaneous transluminal coronary angioplasty has proven to be more effective and safer than thrombolytic therapy for the treatment of acute ST elevation myocardial infarction. Coronary intervention decreases early mortality and the incidence of intracerebral hemorrhage when performed by an experienced interventional team in a timely fashion. After failed fibrinolytic therapy for myocardial infarction, percutaneous transluminal coronary angioplasty is indicated for signs of ischemia and is very effective in restoring vessel patency and reducing mortality when used as a rescue procedure. The glycoprotein IIb-IIIa inhibitors improve outcomes in percutaneous transluminal coronary angioplasty, particularly in patients undergoing stent placement. Percutaneous interventional therapy in acute myocardial infarction is particularly beneficial in patients with cardiogenic shock and effective for saphenous vein graft occlusions, patients with diabetes mellitus, and in the elderly. New devices and drugs are currently being tested for acute myocardial infarction and provide hope for even better interventional therapies in the near future.
Authors:
M A Siddiqui; N Tandon; L Mosley; F M Sheridan; H G Hanley
Related Documents :
10588209 - A randomized trial comparing primary angioplasty with a strategy of short-acting thromb...
11108329 - Acute success rates of percutaneous transluminal coronary angioplasty in the treatment ...
1729849 - Temporal increase in resting coronary blood flow causes an impairment of coronary flow ...
11597359 - Alterations of myocardial ultrasonic tissue characterization by coronary angioplasty in...
11753269 - Angioplasty increases target site concentrations of ciprofloxacin in patients with peri...
10877419 - Percutaneous vascular intervention based on gadolinium-enhanced mr angiography.
23851989 - Hyaluronic acid-based hydrogel induces neovascularization and improves cardiac function...
24599939 - What is the optimal left ventricular ejection fraction cut-off for risk stratification ...
9814799 - Minimally invasive coronary surgery: surgical considerations and assessment of cardiac ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society     Volume:  153     ISSN:  0024-6921     ISO Abbreviation:  J La State Med Soc     Publication Date:  2001 Jun 
Date Detail:
Created Date:  2001-08-01     Completed Date:  2001-08-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7505618     Medline TA:  J La State Med Soc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  292-9     Citation Subset:  IM    
Affiliation:
Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary*
Anticoagulants / therapeutic use
Humans
Myocardial Infarction / therapy*
Stents
Thrombolytic Therapy
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Medical management of acute ST elevation myocardial infarction.
Next Document:  Management of cardiac arrhythmias in acute coronary syndromes.